PIK3CA and bladder transitional cell carcinoma: The phosphatidylinositol 3-kinase (PI3K) pathway, involved in cell growth, tumorigenesis, cell invasion, and drug response, is frequently activated in urothelial bladder cancer (UBC) due to PIK3CA alterations.